| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | NaN | 3,403 | NaN | NaN |
| Depreciation and amortization expenses | NaN | 753 | NaN | NaN |
| Amortization of premiums and accretion of discounts associated with investments, net | NaN | 1,840 | NaN | NaN |
| (gains) losses on investments and from sales of businesses, net | NaN | -1,144 | NaN | NaN |
| (gains) losses on derivatives, net | NaN | -2,310 | NaN | NaN |
| (income) loss from equity method investments, net of dividends or distributions | NaN | -365 | NaN | NaN |
| Interest credited to policyholder account balances | NaN | 9,316 | NaN | NaN |
| Universal life and investment-type product policy fees | NaN | 4,182 | NaN | NaN |
| Change in contractholder-directed equity securities and fair value option securities | NaN | 1,013 | NaN | NaN |
| Change in accrued investment income | NaN | 272 | NaN | NaN |
| Change in premiums, reinsurance and other receivables | NaN | 27 | NaN | NaN |
| Change in market risk benefits | NaN | 235 | NaN | NaN |
| Change in deferred policy acquisition costs and value of business acquired, net | NaN | 1,068 | NaN | NaN |
| Change in income tax | NaN | -624 | NaN | NaN |
| Change in other assets | NaN | 555 | NaN | NaN |
| Change in insurance-related liabilities and policy-related balances | NaN | 7,257 | NaN | NaN |
| Change in other liabilities | NaN | 1,917 | NaN | NaN |
| Other, net | NaN | 443 | NaN | NaN |
| Net cash provided by (used in) operating activities | 2,687 | 7,076 | 3,567 | 2,187 |
| Sales, maturities and repayments of fixed maturity securities available-for-sale | 19,845 | 16,543 | 15,425 | 13,441 |
| Sales, maturities and repayments of equity securities | 8 | 44 | 42 | 45 |
| Sales, maturities and repayments of mortgage loans | 4,226 | 5,398 | 2,827 | 3,187 |
| Sales, maturities and repayments of real estate and real estate joint ventures | 128 | 259 | 174 | 24 |
| Sales, maturities and repayments of other limited partnership interests | 437 | 356 | 165 | 203 |
| Sales, maturities and repayments of short-term investments | 3,693 | 5,122 | 4,139 | 3,296 |
| Purchases of fixed maturity securities available-for-sale | 23,656 | 22,364 | 19,748 | 17,143 |
| Purchases of equity securities | 128 | 5 | 14 | 13 |
| Purchases of mortgage loans | 3,608 | 4,548 | 2,038 | 2,215 |
| Purchases of real estate and real estate joint ventures | 215 | 78 | 168 | 273 |
| Purchases of other limited partnership interests | 381 | 495 | 271 | 372 |
| Purchases of short-term investments | 4,555 | 2,721 | 4,781 | 2,984 |
| Cash received in connection with freestanding derivatives | 601 | 367 | 723 | 635 |
| Cash paid in connection with freestanding derivatives | 1,458 | 1,333 | 1,205 | 946 |
| Purchases of businesses (net of cash received of 172, 0 and 0, respectively) | NaN | 738 | NaN | NaN |
| Payments to acquire interest in joint venture | NaN | 20 | 216 | NaN |
| Net change in policy loans | -54 | -7 | -44 | -57 |
| Net change in other invested assets | 423 | 92 | 103 | -100 |
| Other, net | 23 | -12 | 13 | 23 |
| Net cash provided by (used in) investing activities | -5,455 | -4,286 | -5,018 | -2,981 |
| Policyholder account balances - deposits | 27,366 | 25,419 | 27,181 | 27,064 |
| Policyholder account balances - withdrawals | 24,140 | 24,359 | 25,480 | 24,753 |
| Net change in payables for collateral under securities loaned and other transactions | 1,068 | 65 | 28 | -351 |
| Long-term debt issued | 61 | 0 | 30 | 624 |
| Long-term debt repaid | 53 | 774 | 51 | 3 |
| Collateral financing arrangement repaid | 53 | 46 | 40 | 25 |
| Subordinated debt securities issued | 1,000 | 0 | 0 | 0 |
| Derivatives with certain financing elements and other derivative-related transactions, net | 71 | 115 | 58 | 3 |
| Proceeds from mortgage loan secured financing | 115 | 88 | 17 | 268 |
| Repayments of mortgage loan secured financing | 495 | 364 | 205 | 417 |
| Treasury stock acquired in connection with share repurchases | 755 | 460 | 502 | 510 |
| Redemption of preferred stock | NaN | 0 | 988 | NaN |
| Preferred stock redemption premium | NaN | 0 | 12 | NaN |
| Dividends on preferred stock | 45 | 31 | 66 | 31 |
| Dividends on common stock | 372 | 375 | 378 | 382 |
| Other, net | -67 | -46 | 16 | -32 |
| Net cash provided by (used in) financing activities | 3,559 | -998 | -508 | 1,449 |
| Effect of change in foreign currency exchange rates on cash and cash equivalents balances | -136 | 7 | 14 | 197 |
| Change in cash and cash equivalents | 655 | 1,799 | -1,945 | 852 |
| Cash and cash equivalents, beginning of period | 22,032 | 20,233 | 22,178 | 21,326 |
| Cash and cash equivalents, end of period | 22,687 | 22,032 | 20,233 | 22,178 |
METLIFE INC (MET-PF)
METLIFE INC (MET-PF)